Thessalonki, 18 - 21/04/2024 Makedonia Palace IASIS PHARMA participated in the 19th International Congress of Dermatology & Venereology held on April 18-21, 2024, at the "Makedonia Palace" hotel in Thessaloniki. The conference was organized by the Hellenic Dermatology & Venereology Society. Greek Dermatologists attended the congress and had the chance to visit IASIS PHARMA exhibition stand and got [...]
Athens, 27 – 30/03/2024, Divani Caravel Hotel IASIS PHARMA participated at the “22nd PANHELLENIC DIABETES CONGRESS”, held in Athens, at the Divani Caravel Hotel, showing its active interest in Diabetes Mellitus disease, promoting cornerstone pharmaceutical products for type 2 diabetes. Moreover, IASIS PHARMA is about to invest significantly in T2DM in the near future, launching [...]
IASIS PHARMA is pleased to announce the launch of the new Zylapour® 100 mg x 100 tabs package, which expands the existing Zylapour® 100 mg x 30 tabs & Zylapour® 300 mg x 30 packages. The active substance of Zylapour® is Allopurinol. Allopurinol is in the class of medications called xanthine oxidase inhibitors and it was approved for medical [...]
15 – 17/02/2024 Grand Hyatt Hotel, Athens IASIS PHARMA participated at the “Seminars of the Cardiology Working Groups”, held in Athens, at the Grand Hyatt Athens Hotel, from February 15 to 17, 2024. In IASIS PHARMA exhibition stand, the following products were presented: RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single [...]
We would like to inform you that from 1/15/2024, the tablets coloration of the Calciform® family has changed by virtue of ensuring quality and optimization of the physicochemical characteristics of our products. More specifically the excipient pigment of the effervescent tablets Calciform® – Calcium Carbonate 500mg and Calciform D3® – Calcium Carbonate & Cholecalciferol (1000mg +880 IU), has [...]
26-28/01/2024 Hyatt Regency Hotel, Thessaloniki IASIS PHARMA participated in the 1st International Congress “Thessderma Innovation, Inspiration, Interaction” which held on January 26-28, 2024, at the Hyatt Regency Hotel, in Thessaloniki. The conference was organized by the A' & B' Dermatology Clinics of the Aristotle University of Thessaloniki (A.U.Th.). Dermatologists from all over Greece who attended [...]
12/15/23 – 12/17/2023 VALIS Hotel, Volos IASIS PHARMA participated in the HELLENIC OSTEOPOROSIS FOUNDATION CONFERENCE (HELIOS), held in Volos, at the Valis Hotel, from December 15 to 17, 2023. Τhe annual conference of the Hellenic Osteoporosis Foundation (ΗELIOS) is the main scientific event of the HELIOS Foundation since 1996, involving participations of medical specialties dealing [...]
11/23/23 – 11/26/2023 Hotel Makedonia Palace Thessaloniki IASIS PHARMA participated in the “43rd Pan-Hellenic Gastroenterology Conference” which held on November 23-26, 2023, at Makedonia Palace Hotel in Thessaloniki. At this year's scientific event, the latest data in Gastroenterology and Hepatology were presented, in the context of the lifelong education and information of Gastroenterologists and doctors [...]
Launching the new Chios Mastiha in Powder (package of 15 sachets) expands the well-established Mastiha var.Chia brand. Dr. Christos Kon. Zavos, Gastroenterologist – Hepatologist introduced the product to PharmaQ sales force at the new facilities of Iasis Pharma in Koropi. Dr. Christos Kon. Zavos presented all the Updated Facts, Important Scientific Data & Newest Developments [...]
01-05/11/2023 Dulac, Ioannina IASIS PHARMA participated in the 1st International Congress of Dermatology & Venereology held on November 01-05, 2023, at the "Du Lac" hotel in Ioannina. The conference was organized by the Hellenic Dermatology & Venereology Society together with the Dermatology & Venereology Society of Cyprus. At IASIS PHARMA exhibition stand, the unique Isotroin [...]
